Niron has collected $21.3m in funding from investors including Volvo Cars Tech Fund to build a pilot production facility for its rare earth-free magnets.

University of Minnesota spinout Niron Magnetics has collected $21.3m in funding to build a pilot production facility for its rare earth-free magnets.

Co-founded by Stanford researchers, IgGenix is working on therapies that address severe allergies.

Topas Therapeutics has almost doubled its series B round to $48m thanks to an extension backed by all of its shareholders.

Denso took part in a $71m series D round for artificial intelligence technology provider Blaize while inflammatory disease drug developer Aristea closed a $63m Novo and Arena-backed round.

The newly formed RxCapital has made its first investment, in metabolic and cardiovascular disease drug developer Rivus Pharmaceuticals' $35m series A round.

SAP.io took part in email software provider Sedna's $34m series B round while Byju's picked up BCC-backed learning app developer Toppr in a deal reportedly sized at about $150m.

SoftBank’s Opportunity Fund took part in blockchain payment network Paystand's $50m series C round while Flipkart co-led consumer brand builder G.O.A.T Brand Labs' $36m series A.

Several corporates backed a $68m series D round for microbiome drug developer Vedanta Biosciences while grooming brand owner Pangaea raised the same amount from investors including Unilever.

6 Dimensions Capital-backed neuromodulation technology developer Neuspera closed a $65m round while gene therapy developer Coave Therapeutics hiked its latest round to $39m.